19-18614173-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_012109.3(TMEM59L):c.386C>T(p.Ala129Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000043 in 1,605,020 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012109.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM59L | NM_012109.3 | c.386C>T | p.Ala129Val | missense_variant | 3/8 | ENST00000262817.8 | NP_036241.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM59L | ENST00000262817.8 | c.386C>T | p.Ala129Val | missense_variant | 3/8 | 1 | NM_012109.3 | ENSP00000262817 | P1 | |
TMEM59L | ENST00000594859.5 | n.472C>T | non_coding_transcript_exon_variant | 3/5 | 1 | |||||
TMEM59L | ENST00000600490.5 | c.386C>T | p.Ala129Val | missense_variant | 4/9 | 5 | ENSP00000470879 | P1 | ||
TMEM59L | ENST00000598660.1 | n.468C>T | non_coding_transcript_exon_variant | 3/7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152216Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000652 AC: 15AN: 229894Hom.: 0 AF XY: 0.0000635 AC XY: 8AN XY: 126068
GnomAD4 exome AF: 0.0000351 AC: 51AN: 1452686Hom.: 0 Cov.: 34 AF XY: 0.0000318 AC XY: 23AN XY: 722330
GnomAD4 genome AF: 0.000118 AC: 18AN: 152334Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 05, 2024 | The c.386C>T (p.A129V) alteration is located in exon 3 (coding exon 3) of the TMEM59L gene. This alteration results from a C to T substitution at nucleotide position 386, causing the alanine (A) at amino acid position 129 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at